Encompass Health dividend and valuation

EHC · NYSE · USD

Compare Encompass Health
$133.65Change from previous close: +1.04%Absolute change: +$1.37

Close · November 20, 2026

Valuation

Encompass Health paid $0.78 per share in dividends over the last 12 months (yield 0.6%). Next ex-dividend date: January 4, 2027. The P/E ratio is 21.4. The average price target of 12 analysts is $156.08.

Data as of November 21, 2026

Encompass Health compared with similar companies

Encompass Health's P/E (trailing 12 months): 21.4, +26% against the median of a group of 11 similar companies (16.9).

Encompass Health's metrics compared with similar companies
MetricEncompass HealthMedian25th–75th percentileBand
P/E (trailing 12 months)21.416.912.3 – 30.3Middle
Forward P/E19.415.211.4 – 20.1Middle
EV/EBITDA11.09.777.34 – 16.9Middle
Price/book4.903.853.65 – 4.90Middle
Price/sales2.071.330.83 – 2.82Middle
Gross margin44.1%42.5%29.4% – 44.3%Middle
Operating margin18.4%15.3%11.5% – 19.7%Middle
Net margin10.2%8.1%7.5% – 10.3%Middle
ROE25.1%19.1%13.9% – 24.5%High
Debt/equity0.790.800.74 – 1.26Middle

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Encompass Health: valuation over time

On the latest fiscal year's earnings (2025), Encompass Health's P/E today is 24.1, above the median of its last 10 fiscal years (18.0; between 12.6 and 23.1 from 2016 to 2025). Relative to earnings, the stock costs more than it used to. The dividend yield (0.6%) is below the median of the last 10 fiscal years (1.8%).

Encompass Health P/E and dividend yield at each fiscal year end
Fiscal yearPrice at year endEarnings per shareP/EDividend per shareYield
2025$106.14$5.5419.2$0.720.7%
2024$92.35$4.4620.7$0.640.7%
2023$66.72$3.4719.2$0.600.9%
2022$59.81$2.7022.2$0.861.4%
2021$51.92$4.1112.6$1.122.2%
2020$65.78$2.8523.1$1.121.7%
2019$55.11$3.6115.3$1.102.0%
2018$49.09$2.9316.8$1.042.1%
2017$39.31$2.8413.8$0.982.5%
2016$32.81$2.5912.7$0.942.9%

TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.

TickerLandia analysisHow it is calculated

Other metrics

Valuation multiples

Market cap
$13.11B
Enterprise value
$16.72B
PEG
0.41
EV/revenue
2.64

Profitability and growth

ROA
10.1%
ROIC
14.8%
Revenue growth (year over year)
8.9%
Earnings growth (year over year)
21.6%

Financial health

Total cash
$76.2M
Total debt
$2.8B
Current ratio
1.09
Quick ratio
0.85
Altman Z-Score
3.32
Piotroski F-Score
6.00

Dividends

Annual dividend per share
$0.78
Dividend yield
0.6%
Payout ratio
12.5%
Ex-dividend date
January 4, 2027

Analysts and estimates

Average price target
$156.08
Median price target
$155.00
High price target
$177.00
Low price target
$142.00
Analysts with a price target
12
Forward EPS
$6.89
EPS estimate, current year
$6.28

Shares and trading

Beta
0.67
Average volume
998.15K
Shares outstanding
98.12M
Float
97.15M
Institutional ownership
102.5%
Insider ownership
0.9%
Short interest (% of float)
4.2%
Short ratio (days)
3.19